We are changing the future through regenerative medicine
Evolution of horse health through RegMed
The product, for which a worldwide patent application has been filed, is a combination of a unique machine and a sterile treatment kit. This makes the use of the body’s own stem cells in regenerative medicine accessible to everyone.
The special features of the machine
Flexibility & application:
- Use at the point of care
- High process reliability
- Optimised for mobile treatment
- Lightweight construction thanks to 3D-printed housing
Safety & Function:
- Maximum process safety
- High functionality
- Advanced options: Sterile wound cleaning, etc.
User Experience & Design:
- Easy to use
- Innovative design
- Customised branding
The special features of the treatment set
For maximum safety, our 3D-printed components are manufactured under aseptic conditions in a clean room, where they are also immediately sealed.
To enable you to follow a standardised treatment procedure, you will receive a special treatment kit from one of the leading medical technology wholesalers. This kit contains all the necessary components, which are already sterilised and ready for use.
This enables us to guarantee the following for your daily work and for the health of the horse:
Sterility & Hygiene
Maximum safety through single use
Plastics with pharmaceutical approval
Mostly biodegradable
Biocompatible
Sustainable
Manufactured in a clean room
Highly complex multi-stage filtration
Just-in-sequence packaging system
Fail-safe
Pre-assembled
Adaptability to users
The journey of EquiCell – and where we stand today
Development & Validation
Years of development and testing in close collaboration with a leading European equine clinic. Numerous horses have been successfully treated.
EquiCell open to all veterinarians
The validation phase is complete. EquiCell is now available to all veterinarians. Register now as an official EquiCell partner.
Expansion & Upgrades
For registered EquiCell partners: continuous development of the system with expanded indications and functional upgrades.
Veterinary Q&A: Adipose stem cell therapy in horses (RegMed Vet)
What distinguishes RegMed Vet from other systems?
RegMed Vet uses the clinically established methodology of adipose stem cell therapy, but consistently optimises the extraction process. The system is autologous, enzyme-free and does not use allogeneic stem cells. Processing is carried out without centrifugation, exclusively via filtration and modern fluidic separation using patented 3D-printed filters. Internal laboratory tests with horse fat show a very high cell and SVF yield, at least comparable to centrifuge methods, often exceeding them. The entire process takes less than five minutes and is ideal for point-of-care use.
What clinical studies are available on the efficacy of adipose stem cells in horses?
Extensive preclinical and clinical evidence is available for the use of adipose stem cells (ASC), the stromal vascular fraction (SVF) and the associated secretome (including exosomes) in horses. In established equine osteoarthritis models, intra-articularly administered SVF and MSC preparations showed significant effects on inflammation parameters, joint environment and clinical lameness, while also being very well tolerated. Clinical studies in naturally occurring degenerative joint disease (DJD) also demonstrate a relevant reduction in lameness, in some cases after just one or two treatments within a 90-day follow-up period. Controlled experimental studies are also available for tendon and ligament lesions, showing improved histological fibre organisation and reduced inflammatory response after the application of adipose cell fractions.
How does the therapy compare to PRP, IRAP or surgery?
Compared to PRP or IRAP, which primarily act on the basis of growth factors or cytokines, adipose stem cells exert additional cellular and paracrine effects. These include immunomodulation, regulation of the inflammatory environment and regenerative signals via exosomes. Surgical measures remain essential for structural defects, while adipose stem cell therapies are particularly useful in early to intermediate stages and as an additive measure postoperatively.
How is the success of treatment measured?
The success of treatment is assessed using standardised lameness scores (e.g. AAEP), objective gait analysis, clinical functional testing and imaging techniques (ultrasound, X-ray, MRI). Studies also use synovial biomarkers and histological endpoints.
What is the underlying biological mechanism of action?
The effect of adipose stem cells is mainly based on paracrine mechanisms. The cells have immunomodulatory, anti-inflammatory and pro-regenerative effects. Exosomes and soluble factors play a central role in this process, positively influencing the local tissue environment and supporting the body’s own regeneration.
How are safety and quality monitored?
RegMed Vet relies on a multi-stage safety and quality concept. Extensive laboratory and practical testing was carried out prior to market launch. The first veterinary practices and clinics are subject to close scientific monitoring with standardised clinical checks, outcome documentation and side effect monitoring.
Is there a risk of tumour?
According to current studies, there is no increased tumour risk associated with autologous, minimally manipulated adipose stem cell preparations. No treatment-related oncological side effects have been reported in equine studies.
For veterinarians: Register as an EquiCell partner.
EquiCell is now available to all veterinarians. Register here – we will get back to you.
For horse owners: How does your horse receive the treatment?
Write to us using the contact form. We will help you find an EquiCell partner near you – or provide you with information to pass on directly to your vet.